Evidence from past studies indicated that CDK4 depletion reduced infiltration of CD4+FoxP3+ Tregs (56), and CDK4 inhibitors increased tumor immunogenicity and cytotoxic T cell–mediated clearance of tumor cells (57). Here, CDK4 is linked to neoplasm.